Improving biomedical research with advanced mass spectrometry equipment
A shared Agilent 6546 LC-QTOF for biomedical research
['FUNDING_OTHER'] · AUBURN UNIVERSITY AT AUBURN · NIH-11102316
This study is all about getting a new, advanced machine to help scientists at Auburn University do better research on health and medicine, so they can find new ways to improve treatments and outcomes for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | AUBURN UNIVERSITY AT AUBURN (nih funded) |
| Locations | 1 site (Auburn, UNITED STATES) |
| Trial ID | NIH-11102316 on ClinicalTrials.gov |
What this research studies
This research focuses on acquiring a state-of-the-art Liquid Chromatography Quadrupole Time-of-Flight (LC-QTOF) mass spectrometer to enhance biomedical research capabilities at Auburn University. The new instrument will replace an outdated model that has limited researchers' ability to conduct high-resolution mass analysis, which is crucial for various biomedical studies. By providing advanced instrumentation, the project aims to improve study design, sample preparation, and bioanalysis, ultimately leading to more effective research outcomes. This initiative is expected to foster innovation and increase productivity among researchers working on diverse biomedical projects.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals involved in biomedical studies that require advanced mass spectrometry techniques.
Not a fit: Patients who are not engaged in biomedical research or do not require high-resolution mass spectrometry analysis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the quality and efficiency of biomedical research, leading to better health outcomes.
How similar studies have performed: Other research initiatives have successfully implemented advanced mass spectrometry techniques, indicating a strong potential for success in this approach.
Where this research is happening
Auburn, UNITED STATES
- AUBURN UNIVERSITY AT AUBURN — Auburn, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CALDERON, ANGELA ISABEL — AUBURN UNIVERSITY AT AUBURN
- Study coordinator: CALDERON, ANGELA ISABEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.